Skip to main content

Table 3 Distribution of EPIC hormone function domain items before and after 6 and 12 months of androgen-deprivation therapy

From: Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

 

More than once a day

About once a day

More than once a week

About once a week

Rarely or never

Hot flashes*

 Pre

4.4%

4.4%

0.0%

6.7%

84.4%

 6Mo

33.3%

13.3%

6.7%

0.0%

46.7%

 12Mo

44.4%

8.9%

2.2%

4.4%

40.0%

Breast tenderness

 Pre

2.2%

0.0%

0.0%

0.0%

97.8%

 6Mo

0.0%

2.2%

0.0%

0.0%

97.8%

 12Mo

0.0%

0.0%

2.2%

2.2%

95.6%

Feel depressed

 Pre

0.0%

2.2%

2.2%

13.3%

82.2%

 6Mo

0.0%

2.2%

4.4%

8.9%

84.4%

 12Mo

0.0%

0.0%

4.4%

13.3%

82.2%

Lack of energy

 Pre

0.0%

6.7%

6.7%

22.2%

64.4%

 6Mo

0.0%

4.4%

11.1%

15.6%

68.9%

 12Mo

2.2%

6.7%

15.6%

15.6%

60.0%

 

Gained 5 kg or more

Gained less than 5 kg

No change

Lost less than 5 kg

Lost 5 kg or more

Change in body weight*

 Pre

0.0%

2.2%

93.3%

4.4%

0.0%

 6Mo

2.2%

31.1%

60.0%

6.7%

0.0%

 12Mo

2.2%

35.6%

57.8%

4.4%

0.0%

  1. *p < 0.001.